Haffkine Bio-Pharmaceutical Corporation Ltd. v. M/s Nirlac Chemicals
Background
Haffkine, a Maharashtra government undertaking that manufactures polio vaccines, floated a tender for bulk polio-vaccine drugs. Nirlac Chemicals, the long-time Indian distributor for the Indonesian manufacturer, protested that its bid was rejected and that a rival bidder, Bionet (Thailand), had its bid opened without Nirlac's representatives present, in violation of Central Vigilance Commission (CVC) guidelines on transparent tender openings. The Bombay High Court agreed, quashed the tender and the contract awarded to Bionet, and directed a fresh tender, while permitting Haffkine to keep buying from Bionet in the interim for public-health reasons. Haffkine, Bionet, and Nirlac all appealed to the Supreme Court.
Decision Breakdown
The Supreme Court agreed that the tender process was vitiated because Bionet's bid documents were never shown to Nirlac's representatives, violating the CVC's mandatory transparency guidelines, so Haffkine and Bionet's appeals failed. However, it also held that Nirlac itself was not technically qualified, because it had failed to agree to a tender condition requiring the bidder to help generate a minimum level of future business for Haffkine, so Nirlac's claim to be awarded the contract also failed. Rather than simply ordering a fresh tender (which would delay a drug essential for child immunisation), the Court moulded the relief: it directed Haffkine to procure a calculated quantity (120 million doses) of bulk drug from Nirlac at Nirlac's quoted price, restrained further purchases from Bionet beyond an already-confirmed order, and permitted Haffkine to float a fresh, clearer e-tender for future requirements.
Lesson Learnt
Government tenders must be opened transparently in the presence of all bidders' representatives, including the technical documents: a violation of this rule can void the whole process, even if the complaining bidder is itself not fully qualified; courts may craft a practical, blended remedy rather than a one-size-fits-all order when public interest (here, child vaccination) is at stake.